Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.

Three types of vaccine, all expressing the same antigen from Plasmodium berghei, or a CD8+ T cell epitope from that antigen, were compared for their ability to induce CD8+ T cell responses in mice. Higher levels of lysis and numbers of IFN-gamma secreting T cells were primed with Ty virus-like parti...

书目详细资料
Main Authors:	Gilbert, S, Schneider, J, Plebanski, M, Hannan, C, Blanchard, T, Smith, G, Hill, A
格式:	Journal article
语言:	English
出版:	1999

相似书籍

Clinical development of Modified Vaccinia virus Ankara vaccines.
由: Gilbert, S
出版: (2013)

Clinical development of Modified Vaccinia virus Ankara vaccines
由: Gilbert, S
出版: (2013)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
由: Moorthy, V, et al.
出版: (2003)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
由: Schneider, J, et al.
出版: (1998)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
由: McConkey, S, et al.
出版: (2003)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
由: Moorthy, V, et al.
出版: (2003)

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
由: Moorthy, V, et al.
出版: (2003)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
由: Hanke, T, et al.
出版: (1998)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
由: McConkey, S, et al.
出版: (2003)

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
由: Dégano, P, et al.
出版: (1999)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
由: Dorrell, L, et al.
出版: (2000)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
由: Alharbi, N
出版: (2014)

Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
由: López-Camacho, C, et al.
出版: (2019)

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity
由: Alharbi, N, et al.
出版: (2015)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
由: Rosario, M, et al.
出版: (2010)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
由: Behboudi, S, et al.
出版: (2004)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
由: Mcshane, H, et al.
出版: (2001)

The production of hybrid Ty:IFN virus-like particles in yeast.
由: Malim, M, et al.
出版: (1987)

An immunological analysis of Ty1 virus-like particle structure.
由: Brookman, J, et al.
出版: (1995)

The expression of hybrid HIV:Ty virus-like particles in yeast.
由: Adams, SE, et al.
出版: (1987)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
由: Cottingham, M, et al.
出版: (2008)

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
由: Schneider, J, et al.
出版: (2001)

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
由: Hanke, T, et al.
出版: (1999)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
由: Goonetilleke, N, et al.
出版: (2003)

Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara-vectored ebola vaccines at 1 year
由: Winslow, R, et al.
出版: (2017)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
由: Hanke, T, et al.
出版: (2007)

Virus-like particles as vaccine adjuvants.
由: Gilbert, S
出版: (2001)

Virus-like particle vaccines
由: Mukhopadhyay, E, et al.
出版: (2022)

Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya.
由: Hanke, T, et al.
出版: (2002)

Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
由: Boyd, A, et al.
出版: (2013)

Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus
由: Boyd, A, et al.
出版: (2013)

Reverse transcriptase activity and Ty RNA are associated with virus-like particles in yeast.
由: Mellor, J, et al.
出版: (1985)

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
由: Webster, D, et al.
出版: (2006)

Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
由: Busquets, N, et al.
出版: (2011)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
由: McShane, H, et al.
出版: (2004)

Immunity, safety and protection of an Adenovirus 5 prime--Modified Vaccinia virus Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves.
由: Bull, T, et al.
出版: (2014)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
由: Reyes-Sandoval, A, et al.
出版: (2010)

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
由: Webster, D, et al.
出版: (2005)

A novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs).
由: Gilmour, J, et al.
出版: (1989)

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.
由: Mwau, M, et al.
出版: (2004)